| Scilone Pharma Inlicenses China marketing rights to ProFlow® - A treatment for Peripheral Arterial disease Posted: 26 Jun 2013 11:35 PM PDT SciClone Pharmaceuticals, Inc. will pay to Taiwan Liposome Company (TLC) upto $39.5 million as and when certain clinical, regulatory and sales related milestones are achieved. Under the terms of the... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]  |
| Finland based Biohit healthcare establishes a Joint Venture in China with AnnAnhui Wisdom-Win Investment Co., Ltd. Posted: 26 Jun 2013 10:14 PM PDT Finland based healthcare company Biohit Oyj will be setting up a Joint Venture in China with Anhui Wisdom-Win Investment Co., Ltd. The Joint Venture company will be named Biohit Biotech (Hefei) Co.,... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]  |